Bromocriptine (1.25mg)
Sicriptin 1.25 Tablet is used for high levels of prolactin, female infertility and acromegaly.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Sicriptin 1.25 Tablet is to be taken with food.
Sicriptin 1.25 Tablet is a dopamine receptor agonist. It decreases the release of prolactin (milk hormone) in the body. Overproduction of this hormone is associated with abnormal production of breast milk as well as suppression of the sexual glands which can cause infertility. Reducing prolactin levels with Sicriptin 1.25 Tablet can therefore improve these conditions. In acromegaly, it works by lowering the amount of growth hormone in the body.
Related Warnings
Sicriptin 1.25 Tablet may cause excessive drowsiness and calmness with alcohol.
Sicriptin 1.25 Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Sicriptin 1.25 Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Sicriptin 1.25 Tablet is usually not used during breastfeeding because it suppresses lactation.
Dizziness or weakness due to low blood pressure may occur in some patients while on Sicriptin 1.25 Tablet. If you are affected in this way, your ability to drive may be impaired.
Sicriptin 1.25 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Sicriptin 1.25 Tablet may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Sicriptin 1.25 Tablet in patients with liver disease. Please consult your doctor.
However, a cautious use of this medicine is advised in these patients.
